Brief: Glenmark Pharma Q4 Consol Net Profit 3.01 Billion Rupees
29/05/2026 15:47
BRIEF-Glenmark Pharma Q4 Consol Net Profit 3.01 Billion Rupees May 29 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS:
GLENMARK PHARMA Q4 CONSOL NET PROFIT 3.01 BILLION RUPEES
GLENMARK PHARMA Q4 CONSOL NET SALES 37.6 BILLION RUPEES
GLENMARK PHARMA - DECLARES DIVIDEND OF 2.5 RUPEES PER SHARE
Source text: [ID:]
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter